The intent of this policy/guideline is to provide information to the prescribing practitioner outlining the coverage criteria for Reclast, Zometa and zoledronic
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RECLAST safely and effectively. See full prescribing information for RECLAST. Reclast (zoledronic acid) Injection Initial U.S. Approval: 2024 -INDICATIONS AND USAGE-
The product information contained in this website is intended for general information purposes. RECLAST (zoledronic acid). Reclast is a bisphosphonate
NDC, Product Descriptions, Prescribing information, Dosage Form RECLAST 5MG/100ML 1LIVI US, 1.00 BT, INJECTABLE, Prescribing
Reclast Instructions for Patients. The Endocrine Center Contents Educational Information Reclast (731 reviews). Medical website powered by Tebra. ×
Reclast Prescribing Information. East Hanover, NJ: Novartis Pharmaceutical Corporation; April 2024. Available at
Tymlos (abaloparatide) Prescribing Information. Waltham, MA; Radius Health, Inc. October. 2024. 7. Reclast (zoledronic acid) Prescribing
Prolia [prescribing information]. Thousand Oaks, CA: Amgen Inc.; May 2024. 28. Reclast [prescribing information]. East Hanover, NJ: Novartis Pharmaceuticals
(Reclast), ibandronate). OR b) Member has very high risk for Forteo [prescribing information]. Indianapolis, IN: Lilly USA, LLC
Comments